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Abstract
Influential theoretical accounts take the position that classical conditioning can induce pla-
cebo effects through conscious expectancies. In the current study two different conditioning
procedures (hidden and open) were used to separate expectancy from conditioning in order
to reveal the role of expectancy in the formation of nocebo hyperalgesia. Eighty-seven
healthy females were randomly assigned to three groups (hidden conditioning, open condi-
tioning, and control). Participants were selected according to the Fear of Pain Questionnaire
scores and assigned to two subgroups: high and low level of fear of pain (trait). They
received electrocutaneous pain stimuli preceded by either an orange or blue color. During
the conditioning phase, one color was paired with pain stimuli of moderate intensity (control
stimuli) and the other color was paired with pain stimuli of high intensity (nocebo stimuli) in
both hidden and open conditioning groups. Only participants in the open conditioning group
were informed about this association, however just before the testing phase the expectancy
of hyperalgesia induced in this way was withdrawn. In the control group, both colors were
followed by control pain stimuli. During the testing phase all participants received a series of
stimuli of the same intensity, regardless of the preceding color. Participants rated pain inten-
sity, expectancy of pain intensity and fear (state). We found that nocebo hyperalgesia was
induced by hidden rather than open conditioning. The hidden conditioning procedure did not
produce conscious expectancies related to pain. Nocebo hyperalgesia was induced in par-
ticipants with low and high fear of pain and there was no difference in the magnitude of the
nocebo effect between both groups. Nocebo hyperalgesia was not predicted by the fear of
upcoming painful stimuli.
Introduction
Recent years have seen advances in placebo effect research, but less attention has been paid to
the nocebo effect [1,2]. The term “nocebo effect” was originally coined to describe noxious or
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undesirable effects caused by the use of placebo [3,4], and this way of defining the nocebo
effect remains valid today [5]. However, two phenomena must be distinguished: the placebo
and nocebo effect vs the placebo and nocebo response. The placebo and nocebo effect refers to
". . . the changes specifically attributable to placebo and nocebo mechanisms, including the
neurobiological and psychological mechanisms" [6]. The placebo and nocebo response refers
to the wide range of changes in health condition resulting from the administration of an inac-
tive treatment, including spontaneous remission or regression to the mean [6].
The nocebo effect is an important factor in clinical contexts. It contributes to worsening of
physiological symptoms and to the formation of a variety of adverse treatment effects which
may affect medical adherence and, ultimately, influence medical outcomes [1,2,5,7]. One of
the most studied types of nocebo effect is nocebo hyperalgesia, which manifests itself as an
increase in pain after implementation of a non-hyperalgesic procedure or substance, i.e.
placebo.
Despite the clinical significance of the nocebo effect, its mechanisms have not yet been thor-
oughly investigated. Much more is known about the mechanisms of the placebo effect [8];
however, studies suggest that the nocebo effect is not just the negative counterpart of the pla-
cebo effect [9–11], and the mechanisms underlying these two phenomena may differ [9].
Thus, the results of research on the placebo effect should not be used without prior verification
to explain the nocebo effect.
Expectancy, defined as a “conscious, conceptual belief about the future occurrence of an
event” [12] is indicated as a key mechanism of placebo effects [13–15]. According to this theo-
retical approach, all methods of inducing placebo effects, i.e. classical conditioning, verbal sug-
gestions and observational learning, are mediated by expectancy [15]. The term ‘expectancy’
has even been included in definitions of the nocebo effect [12,16] since the early definition
that was formulated by Hahn [17]. According to this approach, negative outcomes, which are
known as the nocebo effect, are produced by negative expectancies.
At the neural level, it has been shown that negative expectancies and subsequent pain
enhancement are associated with an increase in brain activity observed in cortical regions such
as insula and anterior cingulate cortex (ACC) [18]. The increase in neurophysiological
responses under nocebo treatment has been detected using low alpha EEG and startle reflex
techniques [19]. Nevertheless, not only the brain circuits are involved in the nocebo effect but
also nociceptive filtering at the spinal level [20]. Moreover, studies conducted on animals and
humans have shown that nocebo hyperalgesic effect can be blocked by proglumide, a selective
agonist of cholecystokinin (CCK) type-A/B receptors. It thus seems that the nocebo effect has
strong biological underpinnings [19].
There is evidence that verbally induced expectancies may result in nocebo hyperalgesia
[9,14,21,22]. The results of a few studies suggest that expectancies may be also involved in
nocebo hyperalgesia induced by classical conditioning [23–25]. However, in these studies a
combined procedure comprising classical conditioning and verbal suggestion of hyperalgesia
was used to induce hyperalgesic response. Thus, a definite answer to the question of whether
nocebo hyperalgesia induced by conditioning is mediated by expectancies is not possible on
that basis.
Although the results of a few studies suggest that conscious processes do not necessarily
have to be involved in the classically conditioned nocebo effect [26–33], only in some of them
were self-reported expectancies controlled for and measured trial by trial [26,27]. Thus, further
research is needed to establish the role of conscious processes in shaping classically condi-
tioned nocebo hyperalgesia [34].
To verify whether expectancies are involved in nocebo hyperalgesia, two conditioning pro-
cedures (hidden and open) were compared in this study. In each of these two procedures,
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participants were provided with the same pain experiences, but the information provided to
the participants differed. While participants who had undergone hidden conditioning were
not informed about the relationship between conditioned and unconditioned stimuli, those
subjected to open conditioning were explicitly informed about it. Conscious expectancies
induced in this way were then withdrawn (by informing participants that associations between
stimuli would no longer be in effect), so as to be sure that the nocebo hyperalgesia induced as a
result of this procedure would not be produced by these expectancies. Thus, investigating hid-
den and open conditioning could be a way to disentangle conditioning and expectancies and
could answer the question about the role of conscious processes in the formation of nocebo
hyperalgesia.
It should be noted here that there is a distinction between hidden-open conditioning and
hidden-open treatment. Open conditioning requires informing participants about the rela-
tionship between conditioned and unconditioned stimuli, while hidden conditioning does
not. Hidden-open treatment requires either informing patients or not that they are undergoing
medical treatment [35,36].
So far only four studies have used both open and hidden conditioning to induce placebo
analgesia [37–40]; these studies showed that hidden conditioning produces significant placebo
analgesia, whereas open conditioning elicits a lesser or no effect. The current study is the first
to compare hyperalgesic effects induced by hidden and open conditioning. We hypothesized
that 1) hidden rather than open conditioning would produce the nocebo effect, 2) the nocebo
effect induced by hidden conditioning would be predicted by expectancy.
Another goal of this study was to establish the role of fear in shaping nocebo hyperalgesia
induced by hidden and open conditioning. The results of previous studies showed that fear of
pain, i.e. a relatively stable trait indicating how fearful individuals are of painful stimulation
(hereafter referred to as fear of pain) [41,42] as well as fear of an upcoming painful stimulus,
i.e. fear as a state (hereafter referred to as fear) [43], reduces placebo analgesia induced by ver-
bal suggestions. Although one recent study found that fear predicted placebo analgesia
induced by hidden conditioning [37], another did not confirm that fear predicted either pla-
cebo analgesia or nocebo hyperalgesia induced by hidden conditioning [26]. It has also been
found that fear of pain does not predict classically induced placebo analgesia [37] and may not
be involved in nocebo hyperalgesia [27,28]. To conclude, the data concerning the effect of dis-
positional fear of pain on placebo effects are inconclusive; moreover, they mainly come from
correlational studies focused on placebo analgesia. As we aimed to search for causal relation-
ships, in the current study participants with a high or low level of dispositional fear of pain
were selected to examine the influence of fear of pain on classically induced nocebo hyperalge-
sia. Since previous studies suggest that fear rather than fear of pain may increase the pain expe-
rience, we hypothesized that fear rather than fear of pain would predict nocebo hyperalgesia
induced by hidden conditioning.
Material and methods
Similarly designed screening procedure and experimental sessions have been used in two of
our previous studies [26,37]. The description of the study design in this paper follows closely
the description of the study design from the previous research in which analogous procedures,
i.e. hidden and open conditioning were used to induce the placebo effect [37].
Participants
A total of 87 females (mean age = 23.84 ± 3.20; range = 19–35 years) participated in the study.
Participation in the study was voluntary and financially rewarded. All volunteers were
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subjected to a screening procedure before the beginning of the experiment. They answered a
series of questions concerning their health status. Also, they completed The Hospital Anxiety
and Depression Scale (HADS) [44], which allowed to determine the presence of emotional dis-
orders. Data obtained from the screening procedure was used to exclude from the study those
individuals who: 1) suffered from pain during last month, 2) took painkillers, 3) regularly took
prescribed medications or illegal drugs, 4) overused alcohol or tobacco, 5) have ever had any
neurological, respiratory, circulatory, musculoskeletal, metabolic and/or psychiatric disorders,
5) manifested symptoms of anxiety and/or depression. In addition, volunteers completed The
Fear of Pain Questionnaire (FPQ-III) [45]. On the basis of previous studies, the mean score
and standard deviations of FPQ-III were established [37,43,46,47]. Only those volunteers who
had a score higher than one standard deviation above the mean and those who had a score
lower than one standard deviation from the mean were included in the study. Those with a
medium level of fear of pain (scores 71.10 ± 9.12) were excluded from the experiment. Partici-
pants with high and low levels of fear were randomly assigned to each of the three groups, i.e.
hidden conditioning, open conditioning and control group. Only participants aged 18 to 35
who did not participate in the pain studies previously were enrolled in the experiment.
Participants were informed that the study was aimed to examine the responses to pain
caused by electrical stimulation and that they would receive a series of electrical stimuli during
the experiment. The participants were aware that they could withdraw from participation at
any time. All participants gave their informed written consent to participate in the experiment.
The experimental procedure was conducted in accordance with the principles contained in the
Declaration of Helsinki and was approved by the Research Ethics Committee at the Institute of
Psychology of the Jagiellonian University.
Sample size
The sample size was established based on the results from our previous study on classically
induced nocebo hyperalgesia [26]. It was decided to examine at least 24 subjects per group
because this number covers both planned within-group comparison (fear subgroups with 12
subjects) and planned comparison aimed to compare experimental group to the control group
(14 per group). Calculation was performed using effect size d of 0.92 and 0.99, respectively.
Power calculation was performed a priori for within- and between-group planned-compari-
sons aimed to verify the main hypothesis. Calculation was performed by G�Power (G�Power
3.1.9.2 statistical software [48]) with the alpha level set at 0.05 and 80% power.
Stimuli
The Constant Current High Voltage Stimulator (Digitimer, Welwyn Garden City, England,
Model DS7AH) was used to produce square pulses with a duration of 200 μs. Electrical stimuli
were delivered to participant’s non-dominant forearm through two durable stainless steel-disk
electrodes 8 mm in diameter with 30 mm spacing. Stimuli at two different intensities were
used in the course of experiment. The stimulus at intensity of 2.2T mA (where T is an individ-
ual pain threshold) was paired with nocebo stimulus, while the stimulus at intensity 1.5T mA
was paired with control stimulus. Both coefficients (2.2 and 1.5) were set based on the results
of the preliminary study. They were also used in the previous study [27].
Two color stimuli (blue and orange) were used in this study. Color stimuli were displayed
on the screen (17", resolution 1280 x 1024) placed centrally in front of the participant. One of
the two colors served as nocebo stimulus and was presented before electrical stimuli at higher
intensity, while the other served as control stimulus and preceded electrical stimuli at lower
intensity. The colors were counterbalanced.
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Design and procedure
The experimental session consisted of three phases: calibration, conditioning, and testing
(Fig 1).
Calibration phase. During the calibration phase, the participants received two series of
ascending electrical stimuli starting from 0 mA. Each subsequent stimulus was delivered every
5 seconds and was increased by 0.5 mA. The intensity of the pain stimulus was increased until
the participant reported tactile, nonpainful sensation (t). Then the intensity of the electrical
stimulus was increased until the participant reported the sensation caused by this stimulus as
painful. In this way the tactile threshold (t) and pain threshold (T) were determined twice. The
average T value was used to calculate the intensity of the pain stimulus that was to be paired
Fig 1. Study design. Participants were randomly assigned to the one of three groups: open conditioning, hidden condition or control group. They received series of
electrical stimuli during three successive phases of the experimental session, i.e. calibration, conditioning and testing. Before the conditioning phase, participants in the
open conditioning group were informed that one of the colors, e.g. orange (counterbalanced across participants), was related to the higher intensity of electrical stimuli
(verbal suggestion, VS+), and before the testing phase they were informed that colors were no longer related to the intensity of the electrical stimuli (VS-). Participants in
the hidden conditioning group and control group did not receive any verbal suggestions. Participants in either the hidden conditioning or control group were not
informed about any associations between pain and color stimuli, however, the hidden conditioning group received different stimulus levels depending on the color
displayed on the screen. �Only participants with low or high fear of pain level were included in the study.
https://doi.org/10.1371/journal.pone.0232108.g001
PLOS ONE Classical conditioning elicits nocebo hyperalgesia
PLOS ONE | https://doi.org/10.1371/journal.pone.0232108 May 7, 2020 5 / 20
with the nocebo stimulus (2.2 T mA), as well as the pain stimulus that was to be paired with
the control stimulus (1.5 T mA).
Conditioning phase. The conditioning phase started after a five-minute break. During
this phase of the experiment, the participants received 72 electrical stimuli. The stimuli were
delivered in 4 blocks of 18 stimuli each with a 2-minute break between blocks.
Participants in the hidden and open conditioning groups received pain stimuli at two dif-
ferent intensities, i.e. 1.5T mA and 2.2T mA. The pain stimuli were delivered in the pseudoran-
dom order and were preceded by color stimuli. One of the two colors was presented before
more painful stimuli (nocebo stimulus) and the other was displayed before less painful stimuli
(control stimulus). Participants rated the intensity of the experienced pain, the expectancy of
pain intensity and fear of upcoming pain. They did not provide ratings every time the pain
stimulus was delivered. They were asked to rate their experiences only during the second and
fourth blocks of conditioning. It aimed to focus their attention on pain sensations rather than
pain assessment.
For each of the two blocks, one-third of the stimuli were presented with the scales for the
pain intensity rating, one-third with the scales for the expectancy of pain intensity rating, and
one-third with the scales for the fear rating. Each scale was displayed for six seconds during
the presentation of the color stimulus that was displayed also during the application of pain
stimulus. The scales for the expectancy of pain and fear were displayed before pain stimuli,
whereas the scales for the pain intensity were displayed after pain stimuli (Fig 2).
The conditioning procedure was the same in the hidden conditioning group and the open
conditioning group. The only difference between these two groups was that the participants in
the open conditioning group were informed which of the two colors would precede the less
intense pain stimuli and which would be presented before the more intense pain stimuli.
Participants in the control group received a series of electrical stimuli at the same intensity
1.5T mA. Before each of the stimuli one of the two colors (blue or orange) was presented. The
repeated application of the stimulus at the same intensity allowed to control for the effects of
non-associative learning (sensitization and habituation) and the effects of colors on pain per-
ception [49]. Similarly designed control groups have been used in previous studies in which
placebo analgesia or nocebo hyperalgesia were induced by classical conditioning [9,27,37,50].
Testing phase. The testing phase began two minutes after the conditioning phase was
completed. Participants received 24 electrical stimuli at the same intensity (1.5 mA) preceded
by two color stimuli presented in a pseudorandom sequence. Half of the electrical stimuli was
preceded by orange color and the remaining half was preceded by blue color. Participants
rated intensity of pain, expectancy of pain intensity and fear. The rating scales were displayed
exactly as in the conditioning phase. The pain intensity was rated 12 times, while the expec-
tancy of pain and fear were rated 6 times.
At the beginning of the testing phase, participants in the open conditioning group were
informed that previously established relationship between the colors and the intensity of pain
stimuli would no longer be in effect. Although the colors would be still displayed before the
pain stimuli, they would no longer indicate how intense the upcoming pain stimuli would be.
This information aimed to rule out expectancies that might have been induced in the open
conditioning group. Participants in the hidden conditioning group and the control group did
not receive any additional information.
Measures
The pain intensity, expectancy of pain intensity and fear were measured by means of an
11-point numeric rating scale (NRS). Pain intensity and expectancy of pain intensity were
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rated on the scale ranged from 0 = ‘no pain’ to 10 = ‘the most pain that is tolerable’. Fear was
rated on the scale ranged from 0 = ‘not at all’ to 10 = ‘very much’ (the instruction for fear rat-
ings was: “How much are you afraid of the next pain stimulus”).
The Fear of Pain Questionnaire (FPQ-III) [45] was used to measure the general level of fear
associated with pain. After the testing phase was completed, participants were asked questions
to determine: 1) whether they had figured out the aim of the study, 2) whether they find out
the link between presented colors and pain intensity. After the completion of the study, all par-
ticipants were fully debriefed.
Statistical analysis
Baseline differences in age, pain threshold, tactile threshold, height, and body mass were ana-
lyzed by one-way analysis of variance (ANOVA) with experimental group as a between-subject
factor. To control for differences in pain, pain intensity ratings from the conditioning phase of
the study were compared using a repeated-measures analysis of variance (ANOVA) design,
with experimental group (hidden conditioning, open conditioning, and control group) as a
Fig 2. Study design for the hidden conditioning group (example where orange color stimuli serve as nocebos). Part ‘A’ refers to the course of the
procedure: there were four blocks of conditioning trials, two of which consisted only of color stimuli without any additional instructions (block 1 and 3).
After conditioning, one testing block was applied. Each conditioning block consisted of the application of 18 pain stimuli, whereas the testing block was
comprised of 24 pain stimuli. Orange stimuli (orange vertical bars) served as nocebos (painful intensity, i.e. 2.2T mA), while blue stimuli served as
control stimuli (moderate intensity, i.e. 1.5T mA). During the testing phase, the applied stimuli were of the same moderate intensity (i.e. 1.5T mA),
regardless of the color stimuli. Part ‘B’ refers to the single trial design. Color stimuli were presented for 10 seconds. Note that color stimuli were
presented in three different conditions: 1. with the NRS for fear rating; 2. with the NRS for expectancy rating; and 3. without any additional instruction
before, but with the NRS for pain intensity rating just after the application of the pain stimulus. Each type of the NRS was presented for 6 seconds, which
is the NRS for pain, fear and expectancy. Note that after the presentation of the color stimuli was completed, a pain stimulus of 200 μs duration (depicted
by red lightning) was applied.
https://doi.org/10.1371/journal.pone.0232108.g002
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between-subject factor and condition (nocebo and control) as a within-subject factor. The F-
tests were followed by post-hoc comparisons for the manipulation check. Differences between
nocebo- and control-associated pain ratings (hidden and open conditioning groups); blue-
control- and orange-control-associated pain ratings (control group) were tested with post-hoc
Tukey tests. One additional repeated-measures ANOVA was performed to check whether
there was an expectancy change between the conditioning and testing phase of the study. Dif-
ference in expectancy (nocebo vs. control) was entered as a dependent variable with phase
(conditioning, testing) as a within-subjects factor and group as a between-subjects factor (hid-
den conditioning, open conditioning, and control group). Post-hoc tests were applied in case
of statistically significant main or interaction effects.
In order to verify the hypotheses, data from the testing phase of the study were analyzed.
Statistical comparisons were performed on pain ratings using a repeated-measures mixed
ANOVA design, with experimental group (hidden conditioning, open conditioning, and con-
trol group) and fear of pain (high and low) as between-subject factors and condition (nocebo
and control) as a within-subject factor. The F-tests were followed by within-group planned
comparison tests: nocebo- versus control-associated pain ratings in the (1) hidden and (2)
open conditioning group, and blue-control- versus orange-control-associated ratings in the
(3) control group.
In the next step of the analyses, three between-group planned-comparison tests were per-
formed. (1) To determine whether nocebo hyperalgesia was induced in the hidden condition-
ing group, the mean difference between nocebo- and control-associated pain ratings from the
hidden conditioning group was compared to the mean difference between the two control-
associated pain ratings (blue and orange) from the control group. (2) Similarly, to determine
whether nocebo hyperalgesia was induced in the open conditioning group, the mean differ-
ence between nocebo- and control-associated pain ratings from the open conditioning group
was compared to the mean difference between two control-associated pain ratings (blue and
orange) from the control group. (3) To test whether the magnitude of nocebo hyperalgesia is
greater in the hidden conditioning group than in the open conditioning group, the mean dif-
ference between nocebo- and control-associated pain ratings from the hidden conditioning
group was compared to the mean difference between nocebo- and control-associated pain rat-
ings from the open conditioning group.
To better characterize the observed effects, Spearman correlation coefficients (r) were cal-
culated to determine the degree to which the elicited nocebo hyperalgesia is correlated with
either expectancy of pain intensity or fear. To do this, the mean difference between the
nocebo- and control-associated pain ratings in the testing phase (i.e. nocebo hyperalgesia) was
correlated with the mean differences between the nocebo- and control-associated expectancy
of pain intensity and fear ratings. An independent samples Student t test was applied to com-
pare the magnitudes of these differences between subgroups of participants, i.e. participants
who did or did not declare that there was a relation between the color stimulus and pain
intensity.
All the analyses were conducted using STATISTICA data analysis software, version 12
(StatSoft Inc., Tulsa, OK, USA). The level of significance was set at p< 0.05; the distribution of
data was screened for normality by the Kolmogorov-Smirnov test.
Results
The characteristics of the participants in each experimental group are presented in Table 1. No
significant differences were observed in participant characteristics across the three groups
(Table 1): age (F(2,84) = 0.68; p = 0.51; η2 = 0.02), pain threshold (F(2,84) = 0.83; p = 0.43; η2 =
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0.02), tactile threshold (F(2,84) = 0.05; p = 0.95; η2 = 0.00), height (F(2,84) = 0.36; p = 0.70; η2 =
0.01), and body mass (F(2,84) = 1.07; p = 0.35; η2 = 0.02). The descriptive statistics for all the
analyzed variables are presented in Table 2. For our primary outcome, i.e. pain ratings associ-
ated with control and nocebo stimuli, data were normally distributed which was tested by
visual inspection of the histograms and Kolmogorov-Smirnov test results. In each of the group
pain ratings were normally distributed (p> 0.20).
Manipulation check
ANOVA on the pain intensity ratings from the conditioning phase revealed a statistically sig-
nificant main effect of condition (F(1, 84) = 85.07, p< 0.001, η2 = 0.50) and an interaction
between experimental group and condition (F(2, 84) = 21.88, p< 0.001, η2 = 0.44). No signifi-
cant main effect of the experimental group was found. Post-hoc tests revealed that there were
no differences in control-associated pain ratings across experimental groups, indicating that
pain produced by control stimuli was rated similarly among experimental groups. However,
control stimuli were rated as less painful compared to nocebo stimuli in the open (p< 0.001)
and hidden conditioning groups (p< 0.001), indicating that participants discriminated
between more and less painful stimuli in both experimental groups. In the control group, there
was no difference in pain ratings associated with one color (e.g., orange) compared to control
stimuli associated with another color (e.g., blue).
ANOVA on the difference in expectancy revealed significant main effect of group (F(2, 84) =
4.98, p< 0.01, η2 = 0.11) and phase (F(1, 84) = 13.67, p< 0.001, η2 = 0.14), and group x phase
Table 1. Descriptive statistics of each group: Mean and standard deviations.
Experimental group Fear N t (mA) T (mA) Age (years) Height (cm) Weight (kg) BMI FPQ (score)
Control group - 28 2.21 (0.73) 16.98 (18.86) 23.35 (2.86) 166.00 (5.27) 60.77 (10.16) 23.05 72.00 (24.63)
low 14 2.33 (1.26) 11.82 (10.57) 23.93 (2.46) 167.5 (4.69) 63.64 (11.04) 22.68 50.36 (7.67)
high 14 2.11 (0.77) 13.71 (10.32) 24.71 (3.54) 164.71 (6.29) 57.86 (6.16) 21.32 91.00 (11.78)
Hidden conditioning - 31 2.28 (1.02) 13.56 (7.85) 23.93 (3.70) 167.14 (6.05) 64.21 (11.40) 22.98 74.36 (25.03)
low 15 2.38 (0.75) 21.88 (24.47) 23.27 (1.94) 166.60 (4.69) 63.27 (10.63) 22.80 48.33 (5.54)
high 16 2.05 (0.70) 12.39 (10.29) 23.44 (3.58) 165.44 (5.85) 58.43 (9.42) 21.35 94.19 (9.99)
Open conditioning - 28 2.22 (1.03) 12.77 (10.29) 24.32 (3.02) 166.11 (5.63) 60.75 (9.25) 22.02 70.68 (22.88)
low 13 2.34 (0.92 15.73 (9.10) 23.54 (2.93) 168.00 (5.87) 63.00 (10.68) 22.32 49.31 (8.55)
high 15 2.23 (1.14) 11.68 (6.29) 24.27 (4.33) 166.40 (6.30) 65.27 (12.26) 23.57 96.07 (7.62)
Abbreviations: N, number of subjects in each experimental group; BMI, Body mass index; FPQ-III, Fear of Pain Questionnaire—III.
https://doi.org/10.1371/journal.pone.0232108.t001
Table 2. Pain ratings among examined groups: Mean and standard deviations.
Group N Nocebo stimuli Control stimuli Difference
Hidden conditioning 31 2.13 (1.36) 1.93 (1.22) 0.20 (0.39)
Low fear of pain 15 1.84 (1.26) 1.62 (1.07) 0.22 (0.33)
High fear of pain 16 2.40 (1.44) 2.22 (1.32) 0.18 (0.45)
Open conditioning 28 1.83 (1.12) 1.84 (1.09) - 0.01 (0.32)
Low fear of pain 13 1.31 (0.87) 1.33 (0.89) - 0.03 (0.36)
High fear of pain 15 2.28 (1.14) 2.28 (1.08) 0.00 (0.30)
Control group 28 2.76 (1.71) 2.81 (1.80) - 0.05 (0.35)
Low fear of pain 14 2.45 (1.50) 2.49 (1.59) - 0.04 (0.39)
High fear of pain 14 3.06 (1.90) 3.13 (2.00) - 0.07 (0.32)
https://doi.org/10.1371/journal.pone.0232108.t002
PLOS ONE Classical conditioning elicits nocebo hyperalgesia
PLOS ONE | https://doi.org/10.1371/journal.pone.0232108 May 7, 2020 9 / 20
interaction (F(2, 84) = 9.55, p< 0.001, η2 = 0.19). Post-hoc comparisons revealed that expec-
tancy changed significantly in the testing phase compared to the conditioning phase in the
open-conditioning group only (p< 0.001).
Data from the exit questionnaire revealed that nobody figured out the actual aim of the
study. Two (6%) participants from the control and 12 (39%) from the hidden conditioning
group declared that the color stimuli were associated with pain intensity. Independent samples
Student’s t-test did not reveal statistically significant difference in the magnitude of nocebo
hyperalgesia in the hidden conditioning group between participants who declared that the
color stimuli were associated with pain intensity and those who declared that the color stimuli
were not associated with pain intensity (t (1,29) = 0.10; p = 0.92; d = 0.04). Similar results were
obtained for expectancy of pain intensity (t (1,29) = 1.04; p = 0.31; d = 0.39) and fear ratings (t
(1,29) = 0.81; p = 0.43; d = 0.31).
Nocebo hyperalgesia
ANOVA on the pain intensity ratings from the testing phase of the study revealed a statistically
significant main effect of experimental group (F(2,81) = 3.99; p = 0.02; η2 = 0.09), possibly
reflecting generally higher pain ratings and sensitization in the control group (Table 2). Main
effect of fear of pain (F(1,81) = 5.96; p = 0.02; η2 = 0.07), and an interaction between experimen-
tal group and condition (F(2,81) = 4.19; p = 0.02; η2 = 0.09) were also found. Within-group
planned comparisons on the nocebo- versus control-associated pain ratings revealed a stati-
stically significant difference only in the hidden conditioning group (F(1,81) = 9.38; p = 0.003;
η2 = 0.10; Fig 3). Further analysis revealed that this difference was observed only in the low
fear of pain subgroup (F(1,81) = 5.63; p = 0.02; η2 = 0.06). No difference in the magnitude of the
nocebo effect between participants with low and high fear of pain was found (F(1,81) = 0.12;
p = 0.73; η2 = 0.001).
Between-group planned comparison on the difference between nocebo- and control-associ-
ated pain ratings from the hidden conditioning group compared to the difference between
blue-control- and orange-control-associated pain ratings from the control group revealed a
statistically significant effect (F(1,81) = 7.16; p = 0.009; η2 = 0.08). Subgroup comparisons
revealed a trend for significance in both participants with high (F(1,81) = 3.50; p = 0.06; η2 =
0.04) and low (F(1,81) = 3.66; p = 0.06; η2 = 0.04) fear of pain. Between-group planned compari-
son on the difference between nocebo- and control-associated pain ratings from the hidden
conditioning group compared to the difference from the open conditioning group also
revealed a statistically significant effect (F(1,81) = 5.03; p = 0.03; η2 = 0.06), indicating that the
nocebo hyperalgesia found in the hidden conditioning group was stronger than the effect
found in the control group and the open conditioning group (Figs 3 and 4). No significant dif-
ferences were found within subgroups of high (F(1,81) = 1.84; p = 0.18; η2 = 0.02) and low
(F(1,81) = 3.25; p = 0.08; η2 = 0.04) fear of pain participants. There was also a lack of differences
between the control and open conditioning groups (Fig 4).
Expectancy of pain intensity and fear ratings
The ANOVA on the expectancy of pain intensity ratings from the testing phase of the study
did not reveal a statistically significant main effect of experimental group (F(1,81) = 1.06;
p = 0.35; η2 = 0.03), condition (F(1,81) = 2.32; p = 0.13; η2 = 0.03) or an interaction between
experimental group and condition (F(2,81) = 2.87; p = 0.06; η2 = 0.07). We only found a statisti-
cally significant main effect of fear of pain (F(1,81) = 10.44; p = 0.0018; η2 = 0.11), which indi-
cates that participants with high fear of pain (measured by FPQ-III) expected stronger pain
compared to participants with low fear of pain (Table 3). An analogical pattern of results was
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observed in the ANOVA on fear of pain ratings. No statistically significant main effect of
experimental group (F(2,81) = 0.27; p = 0.76; η2 = 0.007), condition (F(1,81) = 3.61; p = 0.06; η2 =
0.04) nor an interaction between experimental group and condition (F(2,81) = 2.58; p = 0.08; η2
= 0.06) were found. Again, participants with high scores in FPQ-III experienced more fear in
the testing phase of the study compared to participants with low FPQ-III scores (F(1,81) =
14.01; p = 0.0003; η2 = 0.15) (Table 4). Correlational analyses did not reveal significant rela-
tionships between nocebo hyperalgesia and the difference in expectancy of pain intensity and
fear ratings (Table 5).
Discussion
The aim of this study was to use rigorous methods to compare the nocebo hyperalgesic effect
induced by open and hidden conditioning procedures and to investigate the influence of
expectancy and fear as both a trait and a state on the nocebo effect. We found that the nocebo
effect was induced only in the hidden conditioning group. Participants who were not informed
about the relationship between pain and color stimuli experienced more pain in relation to
placebo stimuli than to control stimuli. We did not find any evidence that expectancy of pain
intensity or fear of pain had influenced that effect. Moreover, the data indicate that contin-
gency awareness has not been crucial for the formation of nocebo hyperalgesia.
Fig 3. Mean pain intensity ratings during the conditioning and testing phases of the study (separated by vertical
dotted lines) in A–the hidden conditioning group (nocebo- vs. control-associated ratings), B–the open conditioning
group (nocebo- vs. control-associated ratings), and C–the control group (orange- vs. blue-associated control stimuli).
In the conditioning phase, which was divided into 4 blocks, participants rated pain intensity only in one-third of all
trials during the second and the fourth block of stimuli. In the testing phase of the study, which consisted of 24 control
stimuli, pain intensity was rated 12 times. Error bars represent the SE.
https://doi.org/10.1371/journal.pone.0232108.g003
Fig 4. Between-group comparisons of mean pain intensity. Nocebo hyperalgesia was induced only in the hidden
conditioning group. The difference between mean pain intensities was significant for both the hidden vs. open
conditioning group and hidden conditioning vs. control group. � p< 0.05, �� p< 0.01. Error bars represent the SE.
https://doi.org/10.1371/journal.pone.0232108.g004
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The results of our study extend current theoretical accounts that emphasize the role of con-
scious processes in shaping placebo effects [14,15]. According to the model proposed by Col-
loca and Miller [15], conscious expectancies acquired by decoding information from
psychosocial contexts are central to the formation of placebo effects. However, Benedetti and
colleagues [14] claim that placebo effects in unconscious processes, such as hormone secretion,
may be produced by classical conditioning without the involvement of conscious expectancies.
Our comparison of hidden and open conditioning procedures showed that conscious expec-
tancies may not be involved in the nocebo effect, even in the case of conscious physiological
process, i.e. pain. Moreover, the results revealed that classical conditioning did not generate
consciously accessible expectancies. It has to be noted that the only possible source of expec-
tancies in our hidden conditioning procedure was an experience of the hyperalgesic effect dur-
ing conditioning since color stimuli were the only placebos used in our study. Also, any
conceivable expectancies that could arise were carefully controlled for during the experiment.
Our results lead to the conclusion that conscious processes do not necessarily have to be
involved in the classically conditioned nocebo effect, which is in line with the results of a few
previous studies [24–29] and is consistent with our previous studies, in which the same hidden
conditioning procedure was used to induce nocebo hyperalgesia [26,27,34]. The results of our
study partially confirmed hypothesis that the nocebo effect may be induced by hidden condi-
tioning; however, effects induced in this way were found to be not predicted by conscious
expectancy.
In the open conditioning procedure, direct experience of hyperalgesia was reinforced by
information about the manipulation of pain levels during the procedure. Our results showed
that only in the open conditioning group relevant pain-related expectancies were induced in
Table 3. Expectancy of pain intensity ratings among examined groups: Mean and standard deviations.
Group N Nocebo stimuli Control stimuli Difference
Hidden conditioning 31 2.54 (1.23) 2.26 (1.14) 0.28 (0.58)
Low fear of pain 15 1.98 (1.01) 1.87 (0.99) 0.11 (0.39)
High fear of pain 16 3.06 (1.21) 2.63 (1.18) 0.44 (0.7)
Open conditioning 28 2.02 (1.46) 2.10 (1.59) -0.07 (0.69)
Low fear of pain 13 1.21 (0.84) 1.28 (0.83) -0.08 (0.41)
High fear of pain 15 2.73 (1.53) 2.80 (1.78) -0.07 (0.87)
Control group 28 2.56 (1.78) 2.49 (1.65) 0.07 (0.34)
Low fear of pain 14 2.31 (1.52) 2.31 (1.56) 0.00 (0.23)
High fear of pain 14 2.81 (2.04) 2.67 (1.77) 0.14 (0.43)
https://doi.org/10.1371/journal.pone.0232108.t003
Table 4. Fear ratings among examined groups: Mean and standard deviations.
Group N Nocebo stimuli Control stimuli Difference
Hidden conditioning 31 1.46 (1.30) 1.23 (1.18) 0.24 (0.52)
Low fear of pain 15 0.84 (1.01) 0.64 (0.79) 0.20 (0.37)
High fear of pain 16 2.04 (1.31) 1.77 (1.25) 0.27 (0.65)
Open conditioning 28 1.55 (1.42) 1.27 (1.24) 0.27 (0.93)
Low fear of pain 13 1.00 (1.11) 0.85 (1.08) 0.15 (0.29)
High fear of pain 15 2.02 (1.53) 1.64 (1.29) 0.38 (1.25)
Control group 28 1.51 (1.51) 1.61 (1.63) -0.10 (0.41)
Low fear of pain 14 1.07 (1.5) 1.07 (1.53) 0.00 (0.29)
High fear of pain 14 1.95 (1.43) 2.14 (1.61) -0.19 (0.50)
https://doi.org/10.1371/journal.pone.0232108.t004
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the conditioning phase of the study. However, these conscious expectancies were then deliber-
ately withdrawn before the testing phase by informing participants that the colors were no lon-
ger associated with the levels of pain stimuli. We have shown that expectancies induced in the
conditioning phase were then successfully withdrawn in the testing phase. Moreover, the com-
parison of participants’ pain-related expectancies in the testing phase in the open conditioning
group (where the pain-related suggestion was withdrawn), hidden conditioning group (where
the pain-related suggestion was not provided), and the control group has revealed no signifi-
cant differences. This result shows that we have not only withdrawn previously induced expec-
tancies but we have not produced any new expectancies.
What is more, we did not observe nocebo hyperalgesia in the open conditioning group,
which indicates that withdrawal of existing expectancies may prevent the nocebo effect. This is
in line with the results of studies showing that classically conditioned associations may be abol-
ished by informing participants that previously learned contingencies are no longer in effect
[51–54]. The information about the lack of association between conditioned and uncondi-
tioned stimuli that occurred before the testing phase could have eliminated not only conscious
expectancies but also consciously inaccessible pre-cognitive associations. Our result is in line
with the findings of other studies which failed to induce placebo analgesia [37–40] and nocebo
hyperalgesia [21] with open conditioning. Although our study supports the results of the cited
studies, there are several methodological differences. First, we used a color as a conditioned
stimulus, whereas the previous studies used a cream that could have induced pre-conditioned
expectancies [21,38–40]. Second, in our study participants were informed that pain stimula-
tion would no longer be related to placebo versus control stimuli, whereas in the previous stud-
ies participants were informed that pain stimulation would be equal [21,38,39]. Third, we used
more conditioning trials compared to those studies. Despite these differences, we were unable
to elicit the nocebo effect in the open conditioning group.
The results of previous studies on the role of fear and fear of pain in shaping classically
induced placebo effects have brought inconclusive results. It has been found that fear may be a
predictor of placebo analgesia [37], but other studies did not confirm its role in the formation
of placebo analgesia or nocebo hyperalgesia [26,27]. Similarly, inconclusive results were
obtained in studies examining whether placebo effects would be predicted by fear of pain.
Some previous studies showed that fear of pain was related to placebo analgesia [25], while
other studies found that it was involved in neither placebo analgesia [37] nor nocebo hyperal-
gesia [28]. To establish a causal relationship between fear of pain and the nocebo effect, as well
Table 5. Correlations between nocebo hyperalgesia, fear and expectancy of pain intensity in each of the groups.
Group Fear ratings Expectancy of pain intensity
R p R p
Hidden conditioning 0.22 0.23 0.19 0.30
Low fear of pain 0.29 0.30 0.16 0.56
High fear of pain 0.21 0.45 0.24 0.37
Open conditioning 0.23 0.25 0.14 0.49
Low fear of pain 0.21 0.48 -0.08 0.80
High fear of pain 0.29 0.30 0.26 0.35
Control group -0.15 0.44 -0.26 0.18
Low fear of pain 0.00 1.00 -0.29 0.31
High fear of pain -0.31 0.29 -0.26 0.36
Abbreviations: R, Pearson correlation coefficient.
https://doi.org/10.1371/journal.pone.0232108.t005
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as the differences in hyperalgesic responses in people that differ in the level of fear of pain we
divided participants into low and high fear of pain groups. We found the nocebo effect in par-
ticipants with low and high fear of pain, but there was no difference between both groups.
Moreover, fear did not predict nocebo hyperalgesia induced by hidden conditioning, which
replicates the findings of our previous studies [26]. Thus, the obtained results did not confirm
our hypothesis: they showed that neither fear of pain nor fear are involved in nocebo hyperal-
gesia induced by classical conditioning.
Interestingly, previous brain imaging studies indicated that fear-related areas such as amyg-
dala and right hippocampus are activated during the exposure to nonconscious nocebo cues
[55,56]. Although in our study fear measured at the behavioral level (FPQ-III scores) did not
predict nocebo hyperalgesia, activation of these and other structures (for review see [57])
might explain the observed hyperalgesic effect. Furthermore, recent study by Tinnermann
et al. [58] has shown that nocebo hyperalgesia depends on the cortico-subcortical-spinal inter-
action. Whether our paradigm triggers hyperalgesic effect by means of subcortical structures
dominantly needs to be addressed in future studies.
There are a few advantages of the current study that should be acknowledged. This is the
first study on nocebo hyperalgesia in which the effects of hidden and open conditioning have
been compared. In this study, a neutral stimulus, i.e. not connoted medically, was used to
induce nocebo hyperalgesia to avoid any pre-conditioned expectancies. The use of color as a
placebo allowed us to disentangle treatment expectancies (referring to the treatment effects)
from stimulus expectancies (referring to the noxious stimuli), and investigate the role of the
latter in shaping nocebo hyperalgesia [59]. Furthermore, the sample size was large compared
to the sample sizes of previous studies on the mechanisms of nocebo effects [8,14,21,23,26].
Also, comparison of the hyperalgesic response of participants with high and low dispositional
fear allowed us to examine not only the correlational but also the causal relationship between
fear of pain and nocebo hyperalgesia.
Some limitations of our study should be also discussed. First, only females participated in
the study; in light of sex differences in pain perception [60,61] the results may not be generaliz-
able to men. On the other hand, as only women participated in many of the previous studies,
the results of our study can be directly compared to previous research [9,26,37,38,62–65].
Moreover, a number of studies showed that women are overrepresented among patients with
chronic pain [66]. Therefore, our results can be applied to the majority of the population that
is affected by chronic pain. Second, all the study variables relied on self-reports; however, this
is also the case in the other studies on the mechanisms of the nocebo effect [9,14,23,63,67,68].
Third, the effect size in this study is rather small, but this is not something unusual in experi-
mental pain research, especially in the context of inducing placebo or nocebo effects without
conscious awareness [28,32]. Fourth, although experimentally induced pain in healthy volun-
teers seems to be a good model of clinical pain [69], experimental findings might not be
directly transferable to clinical settings. Fifth, we have investigated the effect of fear of pain on
nocebo hyperalgesia induced by classical conditioning. However, other characteristics (e.g.,
suggestibility) that may influence placebo effects were not controlled for.
The open-hidden paradigm seems to be a promising way of examining placebo effects.
However, it has been used so far in a few studies only. Future research could provide additional
evidence of its usefulness in studying the involvement of conscious processes in placebo effects.
It would also be advisable to develop more implicit methods for the measurement of expectan-
cies in placebo studies. The use of implicit measurement rather than self-rating would provide
further data on the role of expectancy in shaping placebo effects induced by classical condi-
tioning. Moreover, in future experimental studies, it would be valuable to include psychophys-
iological measures, e.g. EEG or EDA. First, to determine whether conscious or unconscious
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processes are involved in placebo effects elicited by hidden and open conditioning. Second, to go
beyond self-reports and expand the results and conclusions to more objective pain indicators.
Our results have implications for medical practice. They show that the occurrence of
nocebo hyperalgesia is not always preceded by conscious expectancies of pain exacerbation.
Thus, pain changes can occur even when patients do not anticipate negative outcomes of the
treatment. The worsening of patients’ condition may result from uncontrollable contextual fac-
tors. Identifying such factors, i.e. the conditioned cues that aggravate pain experiences, could be
a missing part of modern pain management programs. Explicit forms of invasive and non-sur-
gical treatments emphasize the role of physiological change as a basis for pain treatment. This is
not always the case since pain and nociception are two different constructs [70]. Pain is not
always congruent with the magnitude of nociception and our study clearly supports this concept
and indicates that contextual factors such as visual cues might play a role in that incongruence.
It also seems that identifying patients’ baseline characteristics [71], exploring patients’ treat-
ment beliefs and prior negative therapeutic history [16,72], should be another important part
of pain management programs. It would help to identify those who are at risk of nocebo
related effects to take preventive actions. For those patients, special strategies of clinician-
patient communication should be developed to minimize the risk of future nocebo-related
effects [73].
Nocebo and nocebo-related effects are real phenomena that should be considered in the
interpretation of the RCTs. Recent overview of systematic reviews of nocebo effects reported
by patients taking placebos in clinical trials has shown that dropouts and adverse effects attrib-
uted to nocebo effects are more prevalent in placebo groups compared to untreated groups
[74]. Moreover, it seems that the specific treatment effect observed in the RCTs might be
underestimated due to nocebo responses [74,75] caused by e.g. negative context or uncon-
scious conditioned stimuli.
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